Published on 6/1/2019 12:01:00 AM
Abhinav Kurumaddali, MS, Department of Pharmaceutics, University of Florida, Gainesville, Florida
Abhinav began his training in India at one of the top universities, Birla Institute of Technology and Science, Pilani, where he earned his Master's degree in pharmaceutics. In the final semester of his graduate program he had the opportunity to work on his off‐campus Master's thesis at the University of New Mexico. While there, he was involved in developing a dry powder inhalation formulation for the treatment of lung cancer. During this period, he developed a strong interest in learning more about clinical pharmacology and the pharmacometrics aspects of therapeutics to optimizing inhalation drug therapy, which led him to Dr. Hocchaus's lab at University of Florida as a PhD student.
Due to the complexity of dosage form (drug/device combination) and route of administration (locally acting drugs delivered via inhalation to the lungs), establishing the bioequivalence of inhalation drug products is not straightforward. Abhinav's PhD research involves a pharmacokinetic bioequivalence clinical trial sponsored by the FDA. This research is aimed toward investigating novel bioequivalence approaches for inhalation drug products, which could eventually reduce the cost of asthma therapy in the United States. As part of his PhD program, he has had the opportunity to participate in internships both at the FDA and in industry. These internships have broadened his perspective and given him additional insight into the clinical development process of therapeutics. Having developed strong quantitative modeling and analytical skills over the course of his study, Abhinav would like to pursue a career that will enhance his skill set and help solve problems by applying the knowledge of clinical pharmacology and pharmacometrics to support model‐informed drug development. In addition to his current PhD program, Abhinav is also pursuing a Master's degree in biostatistics, which has enhanced his statistical modeling skills.
Colleagues at University of Florida encouraged Abhinav to join ASCPT, describing it as the leading professional organization. His membership in ASCPT has helped him stay up‐to‐date with all the latest advancements taking place in clinical pharmacology and pharmacometrics. The Annual Meeting in particular is a great venue for him to disseminate research findings and network with peers. He explains that the meeting was “a very nice opportunity for students to interact, discuss ideas, and get feedback and good career advice from professionals and leaders of the field working in regulatory agencies, industry, and academia.” His participation in the Annual Meeting was further assisted by receiving a Student/Trainee Travel Grant from ASCPT that helped support his travel for the meeting.
Abhinav has been a member of ASCPT since 2017.